| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |